Patent holdings for IPC class C07D 243/10

Total number of patents in this class: 83

10-year publication summary

2
4
4
5
4
10
1
6
3
1
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Nippon Chemiphar Co., Ltd.
228
14
Boehringer Ingelheim International GmbH
4704
4
Kyushu University, National University Corporation
1643
4
Otsuka Pharmaceutical Co., Ltd.
1502
4
Neuropore Therapies, Inc.
38
3
TONIX Pharmaceuticals Holding Corp
32
3
Tonix Pharmaceuticals, Inc.
41
3
Merck Sharp & Dohme LLC
3741
3
Novartis AG
10904
2
Bristol-myers Squibb Company
4892
2
Boehringer Ingelheim Pharma GmbH & Co. Kg
592
2
Purdue Research Foundation
3564
2
Dana-Farber Cancer Institute, Inc.
2553
2
Gilead Sciences, Inc.
2028
2
ImmunoGen, Inc.
399
2
Merck & Co., Inc.
371
1
Bayer Pharma AG
1061
1
The Regents of the University of Michigan
4670
1
Takeda Pharmaceutical Company Limited
2704
1
Alkermes Pharma Ireland Limited
271
1
Other owners 26